Tim Caulfield writes, “After what feels like a decade of hype and underwhelming sales, direct-to-consumer (DTC) genetic testing seems to be taking off, for better or worse. In the hope of discovering more about themselves, millions of people have sent DNA-filled tubes of spit to commercial testing companies”

Quick Read

Federal regulators approved the first direct-to-consumer test for the BRCA genes, which increase the risk of breast and ovarian cancer, the agency announced on Tuesday

Quick Read

Drugmakers gave millions of dollars to pain-treatment advocacy groups over a five-year period beginning in 2012, in effect promoting opioids to individuals most vulnerable to addiction, according to a new report released Monday by a U.S. senator

Quick Read

When Julia Cheek walked onto the set of “Shark Tank,” her five potential investors wore their trademark scowls. Yet within minutes, their demeanor changed, eyebrows raised and heads nodding as they peppered her with questions about her company, EverlyWell, and its promise to revolutionize medical diagnostics

Quick Read

Maybe you got one of those find-your-ancestry kits over the holidays. You’ve sent off your awkwardly-collected saliva sample and now you’re awaiting your results. If your experience is anything like that of me and my mom, you may find surprises — not the dramatic “switched at birth,” but results that are really different than you expected

Quick Read

BioViva and its controversial CEO Liz Parrish want to bring experimental gene therapies to patients prior to approval by regulators in a quest to cure aging

Quick Read

You might not want to know all of your health results. With comments from our Leila Jamal.

Quick Read

People are starting to alter their own DNA with cheap, easy gene-editing technology. Is it time to regulate CRISPR?

Quick Read